Insights

Expanding Product Portfolio ZARS Pharma has a growing pipeline of proprietary topical anesthetic products, including two approved treatments and several in development, presenting opportunities to partner or expand distribution channels for upcoming launches.

Partnership Expansion The company already collaborates with European partner EuroCept for Synera, indicating potential for further international licensing and distribution agreements to increase market penetration globally.

Market Focus Area Specialization in pain management via topical delivery solutions positions ZARS Pharma to target clinics, hospitals, and aesthetic practices in need of minimally invasive, easy-to-apply anesthetic products.

Niche Consumer Base With FDA-approved products like Pliaglis and Synera designed for dermatologic and procedural markets, there is opportunity to increase sales through aesthetic and dermatology channels driven by rising cosmetic procedures.

Technological Edge Proprietary drug delivery technologies such as CHADD and Peel provide ZARS Pharma with a competitive advantage, enabling the development of unique formulations that can be marketed as innovative solutions in pain management.

ZARS Pharma Tech Stack

Media & News

ZARS Pharma's Email Address Formats

ZARS Pharma uses at least 1 format(s):
ZARS Pharma Email FormatsExamplePercentage
FLast@zars.comJDoe@zars.com
79%
Last@zars.comDoe@zars.com
21%

Frequently Asked Questions

Where is ZARS Pharma's headquarters located?

Minus sign iconPlus sign icon
ZARS Pharma's main headquarters is located at 1142 West 2320 South Salt Lake City, Utah 84119 United States. The company has employees across 3 continents, including North AmericaAsiaAfrica.

What is ZARS Pharma's phone number?

Minus sign iconPlus sign icon
You can contact ZARS Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ZARS Pharma's official website and social media links?

Minus sign iconPlus sign icon
ZARS Pharma's official website is zars.com and has social profiles on LinkedIn.

What is ZARS Pharma's NAICS code?

Minus sign iconPlus sign icon
ZARS Pharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ZARS Pharma have currently?

Minus sign iconPlus sign icon
As of April 2026, ZARS Pharma has approximately 17 employees across 3 continents, including North AmericaAsiaAfrica. Key team members include Chairman: T. S.Owner: W. H.VP, Regulatory Affairs: P. R.. Explore ZARS Pharma's employee directory with LeadIQ.

What industry does ZARS Pharma belong to?

Minus sign iconPlus sign icon
ZARS Pharma operates in the Pharmaceutical Manufacturing industry.

What is ZARS Pharma's email format?

Minus sign iconPlus sign icon
ZARS Pharma's email format typically follows the pattern of FLast@zars.com. Find more ZARS Pharma email formats with LeadIQ.

When was ZARS Pharma founded?

Minus sign iconPlus sign icon
ZARS Pharma was founded in 1996.

ZARS Pharma

Pharmaceutical ManufacturingUtah, United States11-50 Employees

ZARS Pharma is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs using our proprietary drug delivery technologies, primarily in the area of pain management.

ZARS has two approved products and many more in various stages of development.

Synera® (lidocaine 70mg/tetracaine 70mg topical patch) is a topical patch designed to provide local dermal anesthesia for potentially painful superficial procedures, such as venous access procedures involving needles and immunization injections of children. Synera uses our CHADD® technology and a proprietary local anesthetic formulation that contains lidocaine and tetracaine. We are commercializing Synera in the United States and our partner, EuroCept, markets Synera (named Rapydan) in Europe.

Synera resembles a small adhesive bandage in appearance and is applied to the skin before painful medical procedures such as venous access, blood draws, needle injections and minor dermatologic surgical procedures.  Synera is applied for 20 to 30 minutes prior to venous access procedures and needle injections and for 30 minutes prior to minor dermatological procedures. www.synera.com. 

Pliaglis® is a topical local anesthetic cream that provides safe and effective local dermal anesthesia on intact skin prior to painful cosmetic procedures such as dermatologic laser surgery and dermal filler injections. This product consists of a proprietary formulation of lidocaine and tetracaine that utilizes our Peel technology.  Pliaglis should be applied for 20-30 minutes prior to minor dermatological procedures, such as a dermal filler injections, and for 60 minutes prior to major dermatological procedures, such as laser-assisted tattoo removal. Following the application period, Pliaglis can easily be removed from the skin and the procedure can be performed.  Pliaglis is approved by the FDA.  Galderma owns the worldwide marketing rights to the product.

Section iconCompany Overview

Headquarters
1142 West 2320 South Salt Lake City, Utah 84119 United States
Phone number
Website
zars.com
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1996
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $10M$25M

    ZARS Pharma's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    ZARS Pharma's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.